ATC Group: A07BC05 Diosmectite

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A07BC05 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3 A07B Intestinal adsorbents
4 A07BC Other intestinal adsorbents
5 A07BC05 Diosmectite

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 9 g

Active ingredients in A07BC05

Active Ingredient Description

Diosmectite is a natural aluminomagnesium silicate clay with a lamellar, non-fibrous crystalline structure that gives it strong adsorbent properties. Diosmectite has demonstrated efficacy in the treatment of acute watery diarrhoea in children.

Medicines in this ATC group

Ecuador (EC)

Estonia (EE)

France (FR)

Hong Kong (HK)

Lithuania (LT)

Poland (PL)

Romania (RO)

Singapore (SG)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.